FranceFrance

Bio-people

26.11.2005

Neurotech S.A. (Paris, France) has named Ted Danse as new President and Chief Executive Officer. Danse has a record of more than 25 years in life science industries. He served as President and CEO of the public US ophthalmic pharmaceutical company ISTA Pharmaceuticals Inc. and was Director on the boards of Quest Vision Technologies, Inc. and Vision Solutions Technologies, Inc. Other stations of his carreer include business development roles at Coopervision, Bausch & Lomb, Schering-Plough and Allergan.

FranceFrance

22.03.2010

Paris – Despite limited IPO prospects for biotech in general, French Neovacs S.A. said it will raise EUR20 million on the Alternext Exchange of Euronext in Paris. The developer of cytokine inhibiting immunotherapeutics will offer...

FranceFrance

18.03.2010

Marseille – French biotech Trophos has completed enrolment of more than 500 patients suffering from Amyotrophic Lateral Sclerosis (ALS) into a pivotal phase 3 efficacy study of olesoxime (TRO19622). The 18-month registration...

FranceFrance

11.03.2010

Molsheim/Basel – Novartis AG has secured an exclusive option on a lung cancer vaccine, developed by French drug developer Transgene S.A. Upon clinical proof-of-concept of TG4010, an MVA vector that expresses the cancer antigen...

FranceFrance

05.03.2010

Paris – A global effort set to map epigenetic profiles of all 250 human cell types has been kickstarted by international researchers. Top biologists gathered in Paris at the end of January to launch the International Human...

FranceFrance

04.03.2010

Lille/Brussels – The European Commission is accelerating its efforts to create sustainable bio-based industry production processes. Following yesterday’s approval of BASF’s industrial starch potato, Amflora, optimisation of...

FranceFrance

01.02.2010

Cytheris SA has started a Phase IIa clinical programme with its recombinant human Interleukin-7 (CYT107) in the treatment of chronically HIV-1 infected patients classified as immunological non-responders (INR) after at least 12...

FranceFrance

01.02.2010

Paris – French VCs Alain Maiore and Thierry Laugel have teamed up to establish the “Kurma Biofund I”, which will focus on asset-centric programmes emerging from some of Europe’s leading academic institutions. Kurma has completed...

FranceFrance

01.02.2010

Pomacle – Industrial biotech company Bioamber S.A.S. has beaten German chemistry giant BASF in the race to launch the first commercial production of bio-based succinic acid. The company, which is a joint venture between US-based...

FranceFrance

20.01.2010

Dijon – French researchers have unravelled a mechanism that boosts the antitumour effects of the chemotherapeutic drug cyclophosphamide in three different cancer mouse models. The drug efficacy-boosting effect occurred when...

Displaying results 81 to 90 out of 268

< Previous 81-90 Next >

© 2007-2015 BIOCOM

http://www.european-biotechnology-news.com/nc/news/messages-archive/archive-france/browse/8/article/bio-people-2.html

Video

All videos

Product of the week

Products

WhitePaper

LentiKat’s offers an unusual investment opportunity

LentiKat’s owns, manufactures and distributes a patented immobilization into lentil-shaped Lentikats Biocatalysts. The unique lentil-like shape of the Lentikats Biocatalyst ensures unlimited diffusion of substrate(s) into any part of the matrix, while still retaining a convenient size for easy separation from the reaction medium. They find application in the Pharma & Food industry (including bio-based chemicals), Wastewater treatment as well as Biofuels. more...

Events

All Events

Partner-Events

München

BioVaria 2015

Job Advert

Sales Manager

celares GmbH is a Berlin based drug delivery company focused on chemical modifications of biological drugs. We offer customized development services for international pharma and biopharma companies and have manufacturing capabilities for key starting materials used for the preparation of pharmaceutical drugs. For the intensification of our own sales activities we are looking for a sales manager. more...

Stock list

All quotes

TOP

  • CO.DON2.97 EUR2.41%
  • MOLOGEN5.06 EUR0.80%
  • CYTOS1.28 CHF0.79%

FLOP

  • MEDIGENE12.90 EUR-11.03%
  • 4SC1.18 EUR-5.60%
  • PAION2.37 EUR-5.58%

TOP

  • 4SC1.18 EUR71.0%
  • MEDIGENE12.90 EUR63.9%
  • FORMYCON31.00 EUR31.1%

FLOP

  • MORPHOSYS60.74 EUR-13.0%
  • BB BIOTECH281.20 EUR-11.2%
  • EPIGENOMICS5.31 EUR-10.6%

TOP

  • SANTHERA99.75 CHF2709.9%
  • CYTOS1.28 CHF652.9%
  • FORMYCON31.00 EUR336.6%

FLOP

  • MOLOGEN5.06 EUR-53.1%
  • PAION2.37 EUR-22.3%
  • BIOFRONTERA2.57 EUR-21.2%

No liability assumed, Date: 18.04.2015

Current issue

All issues